CYBN Cybin | $0.35 +0.1% | 5/2/2024 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Cybin (OTCMKTS:CYBN) on 5/2/2024 |
RPTX Repare Therapeutics | $3.48 +3.9% | 4/19/2024 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 4/19/2024 |
FUSN Fusion Pharmaceuticals | $21.52 +0.2% | 3/20/2024 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | Low | View details for Bloom Burton rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 3/20/2024 |
RPTX Repare Therapeutics | $3.48 +3.9% | 2/13/2024 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 2/13/2024 |
FUSN Fusion Pharmaceuticals | $21.52 +0.2% | 1/5/2024 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 1/5/2024 |
MBX Microbix Biosystems | C$0.32
| 1/4/2024 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 1/4/2024 |
|
ABCL AbCellera Biologics | $3.92 -3.0% | 11/3/2023 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 11/3/2023 |
MDP Medexus Pharmaceuticals | C$1.62 -0.6% | 6/26/2023 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 6/26/2023 |
OPS Opsens | C$2.90
| 3/28/2023 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Opsens (TSE:OPS) on 3/28/2023 |
RX BioSyent | C$9.05 -0.5% | 3/23/2023 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/23/2023 |
NVC Neovasc | C$1.78 +2.3% | 1/18/2023 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of Neovasc (TSE:NVC) on 1/18/2023 |
DOC CloudMD Software & Services | C$0.05 -10.0% | 11/16/2022 | Upgraded by | Bloom Burton | Analyst P. Pandurangan | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 11/16/2022 |
DOC CloudMD Software & Services | C$0.05 -10.0% | 8/24/2022 | Downgraded by | Bloom Burton | Analyst P. Pandurangan | Buy -> Hold | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 8/24/2022 |
MDNA Medicenna Therapeutics | C$2.85 +22.8% | 8/16/2022 | Target Lowered by | Bloom Burton | - | Buy | C$9.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 8/16/2022 |
MDNA Medicenna Therapeutics | C$2.85 +22.8% | 7/28/2022 | Reiterated by | Bloom Burton | - | Buy | C$11.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 7/28/2022 |
HLS HLS Therapeutics | C$3.72 -7.0% | 7/26/2022 | Reiterated by | Bloom Burton | - | Buy | C$22.00 | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/26/2022 |
MBX Microbix Biosystems | C$0.32
| 6/6/2022 | Reiterated by | Bloom Burton | Analyst A. Borovina | Buy | | N/A | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 6/6/2022 |
MRV Nuvo Pharmaceuticals | C$1.35
| 5/13/2022 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (TSE:MRV) on 5/13/2022 |
GUD Knight Therapeutics | C$6.00 +3.6% | 3/28/2022 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | C$6.70 | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/28/2022 |
GUD Knight Therapeutics | C$6.00 +3.6% | 3/25/2022 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/25/2022 |
RX BioSyent | C$9.05 -0.5% | 3/10/2022 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/10/2022 |
DOC CloudMD Software & Services | C$0.05 -10.0% | 12/22/2021 | Reiterated by | Bloom Burton | Analyst P. Pandurangan | Buy | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 12/22/2021 |
ABCL AbCellera Biologics | $3.92 -3.0% | 12/19/2021 | Reiterated by | Bloom Burton | Analyst A. Borovina | Buy | | Low | View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 12/19/2021 |
TRIL Trillium Therapeutics | C$23.33 +0.5% | 10/1/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Hold | C$18.50 | N/A | View details for Bloom Burton rating of Trillium Therapeutics (TSE:TRIL) on 10/1/2021 |
AUPH Aurinia Pharmaceuticals | $5.42 +0.7% | 10/1/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Hold | $23.00 | Medium | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/1/2021 |
RPTX Repare Therapeutics | $3.48 +3.9% | 9/30/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Buy | $49.00 | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/30/2021 |
MDNA Medicenna Therapeutics | C$2.85 +22.8% | 9/22/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Buy | C$11.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 9/22/2021 |
BLU BELLUS Health | C$19.48 -0.1% | 8/13/2021 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of BELLUS Health (TSE:BLU) on 8/13/2021 |
HLS HLS Therapeutics | C$3.72 -7.0% | 8/5/2021 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/5/2021 |
VMD Viemed Healthcare | $7.41 +2.9% | 8/4/2021 | Upgraded by | Bloom Burton | Analyst P. Pandurangan | Accumulate -> Buy | | Low | View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 8/4/2021 |
VMD Viemed Healthcare | C$10.45 +2.9% | 8/4/2021 | Upgraded by | Bloom Burton | Analyst P. Pandurangan | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Viemed Healthcare (TSE:VMD) on 8/4/2021 |
AUP Aurinia Pharmaceuticals | C$16.76 -3.5% | 5/7/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Aurinia Pharmaceuticals (TSE:AUP) on 5/7/2021 |
AUPH Aurinia Pharmaceuticals | $5.42 +0.7% | 5/7/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | High | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 5/7/2021 |
GUD Knight Therapeutics | C$6.00 +3.6% | 3/26/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/26/2021 |
RX BioSyent | C$9.05 -0.5% | 3/18/2021 | Downgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Hold | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/18/2021 |
MDP Medexus Pharmaceuticals | C$7.75 -4.9% | 2/23/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (CVE:MDP) on 2/23/2021 |
EPIX ESSA Pharma | $6.75 +1.5% | 2/12/2021 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 2/12/2021 |
CRHM CRH Medical | $3.99
| 1/8/2021 | Downgraded by | Bloom Burton | Analyst D. Martin | Hold | $3.00 | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 1/8/2021 |
CRH CRH Medical | C$4.99 +0.4% | 12/23/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of CRH Medical (TSE:CRH) on 12/23/2020 |
CRHM CRH Medical | $3.99
| 12/23/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 12/23/2020 |
Must-See: Elon’s New Invention is Absolutely Insane (Ad) Could Elon's New Device be Bigger than the iPhone?
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…
This mind-blowing new technology could be bigger than the iPhone.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8085&Placement=NativeDisplay&Source=NativeDisplay) Click here for the full story… |
FUSN Fusion Pharmaceuticals | $21.52 +0.2% | 12/17/2020 | Reiterated by | Bloom Burton | Analyst A. Borovina | Buy | | Medium | View details for Bloom Burton rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 12/17/2020 |
MRVFF Nuvo Pharmaceuticals | $0.98 +0.5% | 11/17/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/17/2020 |
AUP Aurinia Pharmaceuticals | C$16.76 -3.5% | 11/3/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Aurinia Pharmaceuticals (TSE:AUP) on 11/3/2020 |
AUPH Aurinia Pharmaceuticals | $5.42 +0.7% | 11/3/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/3/2020 |
VMD Viemed Healthcare | $7.41 +2.9% | 10/19/2020 | Reiterated by | Bloom Burton | Analyst P. Pandurangan | Accumulate | | High | View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 10/19/2020 |
VMD Viemed Healthcare | C$10.45 +2.9% | 10/19/2020 | Reiterated by | Bloom Burton | Analyst P. Pandurangan | Accumulate | | N/A | View details for Bloom Burton rating of Viemed Healthcare (TSE:VMD) on 10/19/2020 |
RPTX Repare Therapeutics | $3.48 +3.9% | 9/17/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | High | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/17/2020 |
HTL Hamilton Thorne | C$1.45 +4.3% | 8/21/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 8/21/2020 |
XENE Xenon Pharmaceuticals | $38.07 -2.5% | 8/13/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $25.00 | Medium | View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 8/13/2020 |
CRH CRH | $81.76 +2.3% | 8/14/2020 | Reiterated by | Bloom Burton | - | Buy | | Low | View details for Bloom Burton rating of CRH (NYSE:CRH) on 8/14/2020 |
CRHM CRH Medical | $3.99
| 8/13/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $4.00 | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/13/2020 |
CRH CRH Medical | C$4.99 +0.4% | 8/12/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of CRH Medical (TSE:CRH) on 8/12/2020 |
CRHM CRH Medical | $3.99
| 8/12/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | High | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/12/2020 |
HLS HLS Therapeutics | C$3.72 -7.0% | 7/21/2020 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/21/2020 |
GUD Knight Therapeutics | C$6.00 +3.6% | 6/29/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 6/29/2020 |
ZYME Zymeworks | $8.48 +0.6% | 6/14/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Zymeworks (NYSE:ZYME) on 6/14/2020 |
EPIX ESSA Pharma | $6.75 +1.5% | 5/24/2020 | Reiterated by | Bloom Burton | - | Buy | $9.00 | High | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/24/2020 |
CPH Cipher Pharmaceuticals | C$8.76 -2.6% | 5/8/2020 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/8/2020 |
HLS HLS Therapeutics | C$3.72 -7.0% | 3/31/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/31/2020 |
RX BioSyent | C$9.05 -0.5% | 3/19/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/19/2020 |
AUPH Aurinia Pharmaceuticals | $5.42 +0.7% | 3/19/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $23.00 | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 3/19/2020 |
COM 138267 (COM.TO) | C$2.95 -2.6% | 12/13/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Sell -> Hold | | N/A | View details for Bloom Burton rating of 138267 (COM.TO) (TSE:COM) on 12/13/2019 |
COM 138267 (COM.TO) | C$2.95 -2.6% | 12/6/2019 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of 138267 (COM.TO) (TSE:COM) on 12/6/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98 +0.5% | 11/12/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/12/2019 |
GUD Knight Therapeutics | C$6.00 +3.6% | 10/22/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 10/22/2019 |
HLS HLS Therapeutics | C$3.72 -7.0% | 10/4/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 10/4/2019 |
AUP Aurinia Pharmaceuticals | C$16.76 -3.5% | 10/2/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Aurinia Pharmaceuticals (TSE:AUP) on 10/2/2019 |
AUPH Aurinia Pharmaceuticals | $5.42 +0.7% | 10/2/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/2/2019 |
RX BioSyent | C$9.05 -0.5% | 8/26/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 8/26/2019 |
CPH Cipher Pharmaceuticals | C$8.76 -2.6% | 8/12/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/12/2019 |
HLS HLS Therapeutics | C$3.72 -7.0% | 8/9/2019 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/9/2019 |
CRHM CRH Medical | $3.99
| 8/1/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/1/2019 |
CRH CRH Medical | C$4.99 +0.4% | 8/1/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of CRH Medical (TSE:CRH) on 8/1/2019 |
BLU BELLUS Health | C$19.48 -0.1% | 8/1/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of BELLUS Health (TSE:BLU) on 8/1/2019 |
MDP Medexus Pharmaceuticals | C$7.75 -4.9% | 7/3/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (CVE:MDP) on 7/3/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98 +0.5% | 5/16/2019 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/16/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98 +0.5% | 4/1/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 4/1/2019 |
HLS HLS Therapeutics | C$3.72 -7.0% | 3/22/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/22/2019 |
CPH Cipher Pharmaceuticals | C$8.76 -2.6% | 3/20/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 3/20/2019 |
CXRXF ADVANZ PHARMA | $17.06 -0.7% | 3/15/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | Low | View details for Bloom Burton rating of ADVANZ PHARMA (OTCMKTS:CXRXF) on 3/15/2019 |
GUD Knight Therapeutics | C$6.00 +3.6% | 11/9/2018 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/9/2018 |
CXR Concordia International | C$25.04 -1.5% | 9/11/2018 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of Concordia International (TSE:CXR) on 9/11/2018 |
BLU BELLUS Health | C$19.48 -0.1% | 7/6/2018 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of BELLUS Health (TSE:BLU) on 7/6/2018 |
MRVFF Nuvo Pharmaceuticals | $0.98 +0.5% | 3/26/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 3/26/2018 |
RX BioSyent | C$9.05 -0.5% | 3/22/2018 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/22/2018 |
ARZ Aralez Pharmaceuticals | C$0.43 +10.3% | 3/14/2018 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Aralez Pharmaceuticals (TSE:ARZ) on 3/14/2018 |
EPI ESSA Pharma | C$8.20 +7.2% | 1/18/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of ESSA Pharma (CVE:EPI) on 1/18/2018 |
EPIX ESSA Pharma | $6.75 +1.5% | 1/18/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | High | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 1/18/2018 |
MRVFF Nuvo Pharmaceuticals | $0.98 +0.5% | 11/3/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/3/2017 |
HTL Hamilton Thorne | C$1.45 +4.3% | 10/25/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 10/25/2017 |
Are You Positioned For The New Energy Goldrush? (Ad) Open AI’s Sam Altman recently helped this company raise $577 million in funding…
What’s more is, It has already inked deals with the Department of Energy.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8003&Placement=NativeDisplay&Source=NativeDisplay) Click here to get all the information about it. |
EPIX ESSA Pharma | $6.75 +1.5% | 9/12/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | Low | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 9/12/2017 |
CPH Cipher Pharmaceuticals | C$8.76 -2.6% | 8/14/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/14/2017 |
CRH CRH Medical | C$4.99 +0.4% | 7/14/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of CRH Medical (TSE:CRH) on 7/14/2017 |
CRHM CRH Medical | $3.99
| 7/14/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 7/14/2017 |
EPIX ESSA Pharma | $6.75 +1.5% | 5/18/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/18/2017 |
MRVFF Nuvo Pharmaceuticals | $0.98 +0.5% | 5/15/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/15/2017 |
CPH Cipher Pharmaceuticals | C$8.76 -2.6% | 5/12/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/12/2017 |
MRVFF Nuvo Pharmaceuticals | $0.98 +0.5% | 5/9/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Hold | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/9/2017 |
ARZ Aralez Pharmaceuticals | C$0.43 +10.3% | 4/10/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Aralez Pharmaceuticals (TSE:ARZ) on 4/10/2017 |
BLU BELLUS Health | C$19.48 -0.1% | 3/1/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of BELLUS Health (TSE:BLU) on 3/1/2017 |
CRH CRH Medical | C$4.99 +0.4% | 2/24/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of CRH Medical (TSE:CRH) on 2/24/2017 |
CRHM CRH Medical | $3.99
| 2/24/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 2/24/2017 |
RX BioSyent | C$9.05 -0.5% | 2/13/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 2/13/2017 |
MSL Merus Labs International | C$1.65 +0.6% | 2/13/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of Merus Labs International (TSE:MSL) on 2/13/2017 |
CPH Cipher Pharmaceuticals | C$8.76 -2.6% | 2/13/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 2/13/2017 |
ABUS Arbutus Biopharma | $3.36 +1.2% | 1/9/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 1/9/2017 |
XENE Xenon Pharmaceuticals | $38.07 -2.5% | 12/22/2016 | Initiated by | Bloom Burton | - | Buy | $14.50 | N/A | View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 12/22/2016 |
ABUS Arbutus Biopharma | $3.36 +1.2% | 12/14/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 12/14/2016 |
GUD Knight Therapeutics | C$6.00 +3.6% | 11/10/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/10/2016 |
COM 138267 (COM.TO) | C$2.95 -2.6% | 11/9/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of 138267 (COM.TO) (TSE:COM) on 11/9/2016 |
CXR Concordia International | C$25.04 -1.5% | 11/7/2016 | Downgraded by | Bloom Burton | Analyst D. Martin | Hold -> Sell | | N/A | View details for Bloom Burton rating of Concordia International (TSE:CXR) on 11/7/2016 |
AUP Aurinia Pharmaceuticals | C$16.76 -3.5% | 11/4/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Aurinia Pharmaceuticals (TSE:AUP) on 11/4/2016 |
AUPH Aurinia Pharmaceuticals | $5.42 +0.7% | 11/4/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/4/2016 |
MRVFF Nuvo Pharmaceuticals | $0.98 +0.5% | 11/2/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/2/2016 |
CRH CRH Medical | C$4.99 +0.4% | 10/28/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of CRH Medical (TSE:CRH) on 10/28/2016 |
CRHM CRH Medical | $3.99
| 10/28/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 10/28/2016 |
CXR Concordia International | C$25.04 -1.5% | 10/26/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of Concordia International (TSE:CXR) on 10/26/2016 |
PLI ProMetic Life Sciences | C$13.60 +0.2% | 10/13/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of ProMetic Life Sciences (TSE:PLI) on 10/13/2016 |
ACHV Achieve Life Sciences | $5.22 -1.5% | 5/3/2013 | Target Raised by | Bloom Burton | - | Buy | $4,000.00 -> $5,000.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/3/2013 |
ACHV Achieve Life Sciences | $5.22 -1.5% | 3/8/2013 | Target Raised by | Bloom Burton | - | | $3,600.00 -> $4,000.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 3/8/2013 |
ONC Oncolytics Biotech | C$1.46 -0.7% | 12/18/2012 | Downgraded by | Bloom Burton | - | Buy -> Hold | | N/A | View details for Bloom Burton rating of Oncolytics Biotech (TSE:ONC) on 12/18/2012 |
THTX Theratechnologies | $1.25
| 6/25/2012 | Downgraded by | Bloom Burton | - | Hold -> Sell | $2.50 -> $0.75 | N/A | View details for Bloom Burton rating of Theratechnologies (NASDAQ:THTX) on 6/25/2012 |
ACHV Achieve Life Sciences | $5.22 -1.5% | 5/4/2012 | Target Lowered by | Bloom Burton | - | Buy | $3,800.00 -> $3,600.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/4/2012 |